Precigen, Inc. (PGEN)
3.70
+0.13
(+3.64%)
USD |
NASDAQ |
Jun 09, 15:32
Precigen SG&A Expense (Quarterly) : 21.05M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Abeona Therapeutics, Inc. | 19.50M |
| Insight Molecular Diagnostics, Inc. | 5.393M |
| Precision BioSciences, Inc. | 6.803M |
| Design Therapeutics, Inc. | 5.327M |
| Agenus, Inc. | 6.86M |